Call for Abstracts 

OCMF is now accepting abstracts for oral presentations for the upcoming Ovarian Cancer Midwest Focus (OCMF) Virtual Conference

November 5-6, 2020

Program Chairs:

Dr. Martina Bazzaro, University of Minnesota-Twin Cities Campus

Dr. Ilana Chefetz,The Hormel Institute, University of Minnesota

Dr. Melissa Geller, University of Minnesota-Twin Cities Campus



The 2020 Ovarian Cancer Midwest Focus Conference will focus on basic science, translational and clinical topics on ovarian cancer, and will offer sessions on emerging topics including Early Detection, Immunotherapy, Novel Therapeutics, Metabolism, Preclinical Models of Ovarian Cancer, Personalized Medicine, Microenvironment, Epigenetics, PARP Inhibitors, Chemoresistance, Combination Therapy, Clinical Studies, Technology Commercialization, and Career Development (virtual lunch and learn).

OCMF looks to provide a collaborative environment which will allow an interdisciplinary approach to ovarian cancer research, hence a broad range of speakers and topics are actively encouraged. We seek session abstracts for oral presentations that address topic areas related to ovarian cancer research, including:

  • Preclinical models of ovarian cancer
  • Metabolism
  • Novel Therapeutics
  • Immunotherapy
  • Personalized medicine
  • Early detection

Selected presentations will be grouped into topical sessions.



OCMF will take place over 2 days. The Symposium will begin virtually on Thursday morning. The conference is single-track (no concurrent sessions) so that all attendees hear all presentations and discussions. Keynote speakers will open each day followed by oral presentations. The full day session on Friday will offer a panel discussion on a relevant issue.

Among the keynote speakers are Dr. Ernst Lengyel, from the University of Chicago, who will talk about cancer metabolism, Dr. Ronny Drapkin, from the University of Pennsylvania, with his talk about epigenetics, Dr. Patricia Modrow, from the Department of Defense, who will talk about Career Development, Dr. Hans Clevers, from the Hubrecht Institute for Developmental Biology and Stem Cell Research, who will be presenting on preclinical models, and Dr. Michael Anglesio, from the British Columbia Health Care, who will talk about personalized medicine.



OCMF will have invited speakers and oral presentations delivered in topical sessions.  Oral presentations are 10 minutes in length and are given in a plenary format to an interdisciplinary audience of approximately 100 attendees. Hence, the content should be interesting to a diverse audience and clearly focused to deliver two or three key points.


The deadline for oral presentation proposals is October 5th, 2020.


Submit a session proposal for oral presentation abstract.
For Questions Contact:

Olivia Niles, 612–624–8003 or